Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Product details Net content: 30 mg per vial Format: Lyophilized material Container: 3 mL glass vial Lot/batch: Recorded on product label where available Intended use Non-clinical laboratory research Analytical reference and assay development Use only in accordance with institutional SOPs and applicable regulatory requirements Not for human or animal consumption Not for clinical, therapeutic, or diagnostic use Certificate of Analysis (COA) For full quality details, please refer to the second and third images on this page for the Certificate of Analysis (COA) for Tirzepatide Canada 30mg
Bioanalysis 12 , 981990 (2020)
WADA Prohibited List International Standard
Available dual-combination products containing basal insulin plus a GLP-1 RA include insulin degludec plus liraglutide and insulin glargine plus lixisenatide
Sign up through your patient portal today
US$ 21.65
US$ 23.93
US$ 20.20
US$ 23.60
